Overall market sentiment has been down on Castle Biosciences Inc (CSTL) stock lately. CSTL receives a Bearish rating from InvestorsObserver's Stock Sentiment Indicator.
What is Stock Sentiment?
In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company.
Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor.
InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon.
The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.
What's Happening With CSTL Stock Today?
Castle Biosciences Inc (CSTL) stock is trading at $71.24 as of 1:09 PM on Wednesday, Apr 14, a gain of $2.67, or 3.9% from the previous closing price of $68.57. The stock has traded between $68.69 and $71.97 so far today. Volume today is low. So far 101,535 shares have traded compared to average volume of 374,039 shares.
To screen for more stocks like Castle Biosciences Inc click here.
More About Castle Biosciences Inc
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.
Click Here to get the full Stock Score Report on Castle Biosciences Inc (CSTL) Stock.
